The core 3E team has more than 10 years of healthcare investment experience and industry expertise in pharmaceutical and biotech.
Join UsDr. Joy Yang joined 3E Bioventures Capital as Venture Partner in 2018. Prior to 3E, Dr. Yang was Vice President at Aura Partners, a Pharmaceutical Consulting firm. Dr. Yang gained her life science and industry experience working at Pfizer, Chemdex, and GE Healthcare.
Dr. Yang received her Ph.D. degree from Northwestern University and was a postdoctoral fellow at Stanford University.